Olympus Gets Another FDA Warning Letter for Failing to Address Duodenoscope Complaints
The FDA has issued another warning letter to Olympus Medical, indicating the company has ignored complaints over problems with its duodenoscopes.
The FDA has issued another warning letter to Olympus Medical, indicating the company has ignored complaints over problems with its duodenoscopes.
The FDA has issued warning letters to Olympus over a failure to meet quality control requirements, including reporting of complaints, involving its endoscope products.
The FDA is warning that certain urological endoscopes have been linked to hundreds of infections and several deaths in recent years.
The FDA says current duodenoscope designs cannot be adequately cleaned, and are calling for hospitals to shift to designs that are disposable or have disposable components.
Some medical experts are calling for duodenoscopes to be removed from the market, due to problems sterilizing them and the risk of patient infections.
The FDA received more than 200 adverse event reports linked to duodenoscopes since October, including 45 incidents of patient infections.
The FDA warns that duodenoscopes are still showing higher-than-expected infection rates despite updated cleaning instructions and design changes.
The FDA has cleared Custom Ultrasonics AERs for the cleaning of some duodenoscopes, which have been linked to hospital infection outbreaks.
The FDA has issued warning letters to the three manufacturers of duodenoscopes, warning that they have fallen behind on required postmarketing studies imposed after a number of infection outbreaks were…
The FDA has issued new voluntary protocols for hospitals to help ensure that duodenoscopes are properly cleaned and sanitized following a number of deadly hospital infection outbreaks in recent years.